Pasar al contenido principal

REGULACION DE LA TRANSICION G2/M EN LA ESTABILIDAD CROMOSOMICA Y EN PATOLOGIAS HUMANAS

BFU2012-39521

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2012
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Secretaría de Estado de Investigación, Desarrollo e Innovación
Centro beneficiario FUNDACIO INSTITUT DE RECERCA BIOMEDICA (BARCELONA)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

GEMC1 is a critical regulator of multiciliated cell differentiation.

  • Terré, Berta
  • Piergiovanni, Gabriele
  • Segura-Bayona, Sandra
  • Gil Gómez, Gabriel
  • Youssef, Sameh A.
  • Attolini, Camille Stephan-Otto
  • Wilsch-Bräuninger, Michaela
  • Jung, Carole
  • Rojas Mendoza, Ana Maria
  • Marjanovi c, Marko
  • Knobel, Philip A.
  • Palenzuela, Lluís
  • López-Rovira, Teresa
  • Forrow, Stephen
  • Huttner, Wieland B.
  • Valverde, M. A. (Miguel Ángel), 1963-
  • de Bruin, Alain
  • Costanzo, Vincenzo
  • Stracker, Travis
The generation of multiciliated cells (MCCs) is required for the proper function of many tissues, including the respiratory tract, brain, and germline. Defects in MCC development have been demonstrated to cause a subclass of mucociliary clearance disorders termed reduced generation of multiple motile cilia (RGMC). To date, only two genes, Multicilin (MCIDAS) and cyclin O (CCNO) have been identified in this disorder in humans., We thank the Ministerio de Economía y Competitividad (MINECO) for funding to TS (BFU2012-39521) and MAV (SAF2012-38140; Fondo de Investigación Sanitaria (RD12/0042/0014); FEDER Funds); G.G.-G. is supported by ISCIII (PI13/00864); V.C. is funded by the Associazione Italiana per Ricerca sul Cancro (AIRC), the European Research Council (ERC) consolidator grant (614541), the Association for International Cancer Research (AICR) (13-0026), the Giovanni Armenise Award to V.C., the Epigen Progetto Bandiera (4.7) and the Fondazione Telethon (GGP13071); G.P. was supported by AIRC Borsa: Fondazione Giovanna Ciani Rif. 16444; S.S.B. was supported by a fellowship from Fundació La Caixa; P.A.K. was supported by an Early Postdoc Mobility Fellowship from the Swiss National Science Foundation; and B.T. was supported by a Severo Ochoa FPI Fellowship (MINECO). IRB Barcelona is a Severo Ochoa Award of Excellence Recipient (MINECO).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

GEMC1 is a critical regulator of multiciliated cell differentiation.

  • Terré, Berta
  • Piergiovanni, Gabriele
  • Segura-Bayona, Sandra
  • Gil Gómez, Gabriel
  • Youssef, Sameh A.
  • Attolini, Camille Stephan-Otto
  • Wilsch-Bräuninger, Michaela
  • Jung, Carole
  • Rojas Mendoza, Ana Maria
  • Marjanovi c, Marko
  • Knobel, Philip A.
  • Palenzuela, Lluís
  • López-Rovira, Teresa
  • Forrow, Stephen
  • Huttner, Wieland B.
  • Valverde, M. A. (Miguel Ángel), 1963-
  • de Bruin, Alain
  • Costanzo, Vincenzo
  • Stracker, Travis
The generation of multiciliated cells (MCCs) is required for the proper function of many tissues, including the respiratory tract, brain, and germline. Defects in MCC development have been demonstrated to cause a subclass of mucociliary clearance disorders termed reduced generation of multiple motile cilia (RGMC). To date, only two genes, Multicilin (MCIDAS) and cyclin O (CCNO) have been identified in this disorder in humans., We thank the Ministerio de Economía y Competitividad (MINECO) for funding to TS (BFU2012-39521) and MAV (SAF2012-38140; Fondo de Investigación Sanitaria (RD12/0042/0014); FEDER Funds); G.G.-G. is supported by ISCIII (PI13/00864); V.C. is funded by the Associazione Italiana per Ricerca sul Cancro (AIRC), the European Research Council (ERC) consolidator grant (614541), the Association for International Cancer Research (AICR) (13-0026), the Giovanni Armenise Award to V.C., the Epigen Progetto Bandiera (4.7) and the Fondazione Telethon (GGP13071); G.P. was supported by AIRC Borsa: Fondazione Giovanna Ciani Rif. 16444; S.S.B. was supported by a fellowship from Fundació La Caixa; P.A.K. was supported by an Early Postdoc Mobility Fellowship from the Swiss National Science Foundation; and B.T. was supported by a Severo Ochoa FPI Fellowship (MINECO). IRB Barcelona is a Severo Ochoa Award of Excellence Recipient (MINECO).